Gerresheimer AG : Destocking to come to an end, lower end of guidance only impacts top line
>Primary Packaging Glass – Destocking to end in H2 - Destocking at glass vials started in Q3 2023 and has had a stronger impact than previously assumed. While the company described the initial destocking as already phased out, management acknowledged that destocking has been expanded towards some other areas on the back of working capital considerations of customers. However, Gerresheimer is confident that despite the fact that destocking takes a little bit longer, it...Gerresheimer is a holding company. Through its subsidiaries, Co. manufactures glass and plastic products for the pharma and healthcare industry. Co.'s operates in three divisions: Plastics & Devices, which its product portfolio includes products for the administration of medicines, such as insulin pens, inhalers, and prefillable syringes; Primary Packaging Glass, which produces glass primary packaging for medicines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, perfume flacons, and cream jars; and Life Science Research, which produces laboratory glassware for research, development, and analytics, such as beakers, Erlenmeyer flasks, and measuring cylinders.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.